Financial Statements Release 2008

February 24, 2009 12:14 ET | Source: Genmab A/S Genmab A/S

In order to read Genmab's Financial Statements Release 2008, please see the
attached file.

Attachments

052009_financialstatement2008_240209_uk.pdf

052009_financialstatement2008_240209_uk.pdf...

Recommended Reading

January 16, 2026 13:30 ET | Source: Genmab A/S

Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Company Announcement Based on the topline results from the EPCORE® DLBCL-1 trial, Genmab will engage global regulatory authorities to discuss next steps COPENHAGEN, Denmark; January 16, 2026 –...
Read More

$Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)$
January 07, 2026 09:00 ET | Source: Genmab A/S

Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence

Media ReleaseCOPENHAGEN, Denmark; January 07, 2026 Supports Genmab’s ambition to build an AI-enabled innovation model that advances the company’s vision of bringing transformative antibody...
Read More